series-a
Stage
2024
Founded
3
Investors
About
Alex Therapeutics develops evidence-based companion apps and AI-driven digital therapies as Software as a Medical Device (SaMD) to help patients manage medications and mental health challenges, partnering with pharmaceutical companies on indication-specific solutions for cancer, rare diseases, and other complex conditions.
Explore Alex Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.